Posts Tagged ‘pharmaceutical stocks’

« Older Entries
Newer Entries »

THLD soars, C sells, ISPH stumbles

Monday, January 3rd, 2011

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) started 2011 higher 34.08 percent in price Monday to $1.81. Volume of 49,432 shares closed in on its all-day average of 94,631. THLD, based in Redwood City, Calif., Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Citigroup Inc. (NYSE: C) did a brisk business the first Monday after New Year, trading in 43,054,072 shares, making up ground on its daily average of 538,216,000. Prices for the stock pushed ahead 1.8 percent to $4.82, on announcing that on New Year’s Eve, C it had completed transactions with Discover Financial Services and SLM Corporation that resulted in the divestiture of its student loan business, The Student Loan Corporation.

Inspire Pharmaceuticals Inc. (Nasdaq: ISPH) listed downward Monday, losing 58.45 percent in price to $3.49, on volume of 6,848,880 shares, dwarfing a full-day average of 577,058. ISPH announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

Tags: , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | No Comments »

BBX takes flight, MU solid, ACUR drubbed

Wednesday, December 22nd, 2010

BankAtlantic Bancorp, Inc. (NYSE: BBX) propelled itself higher 15.24 percent in price Wednesday to $1.21. Volume of 3,957,107 shares was more than six times its daily average, as BBX joined lots of regional banks in popping in price Wednesday.

Micron Technology Inc. (Nasdaq: MU) traded in 31,662,200 shares Wednesday, closing in against its daily average of 33,146,500. Prices for MU inched up 1.6 percent to $8.27. MU was set to announce first fiscal-quarter earnings after the closing bell.

Acura Pharmaceuticals Inc. (Nasdaq: ACUR) took it on the chin Wednesday, losing 12.8 percent in price Wednesday to $3.27, on volume of 410,363 shares, or 11 times its full-day average. ACUR is a specialty pharmaceutical company out of Palatine, Illinois.

Tags: , , , , , ,
Posted in Financial Stocks, Health Care Stocks, Technology Stocks | No Comments »

CNET sings, INTC volume frontrunner, CPIX downward

Wednesday, December 22nd, 2010

ChinaNet Online Holdings Inc. (Nasdaq: CNET) moved higher by 20.79 percent in price Wednesday to $4.30. Volume of 269,526 shares was more than 13 times its daily average. The China-based CNET is a leading full-service B2B media development and internet technology company for small and medium-sized enterprises.

Intel Corp. (Nasdaq: INTC) traded in 32,828,220 shares Wednesday. Although Intel is currently a volume leader, it fell short, in light trading, of its usual volume of 57,889,900. Share prices were down 1% to $220.89.

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) retreated 13.04 percent in price Wednesday to $6.00, on volume of 293,784 shares, compared to a full-day average of 64,679. Nashville-based CPIX announced today that it has received a Complete Response Letter from the FDA regarding its supplemental new drug application (sNDA) for Acetadote® (acetylcysteine) Injection to treat patients with non-acetaminophen induced acute liver failure.

Tags: , , , , , ,
Posted in Health Care Stocks, Technology Stocks | No Comments »

PPHM gets oomph, GE trades widely, NAII loses strength

Monday, December 20th, 2010

Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) added 34.34 percent in price Monday to close at $2.23. Volume of 3,418,741 shares proved more than five times its daily average. The Calif.-based PPHM, a clinical-stage biopharmaceutical company today announced the completion of enrollment in the company’s Phase II dose confirmation trial of Cotara® in patients with recurrent glioblastoma multiforme (GBM), the deadliest form of brain cancer.

General Electric Company (NYSE: GE) traded in 40,410,548 shares, making it a volume leader, but falling short of its daily average of 59,801,500. Share prices were flat at $17.70. GE has received and is reviewing the engineering performance standards issued today by the U.S. Environmental Protection Agency for the second phase of the Hudson River dredging project, one of the largest environmental cleanups ever conducted in the United States.

Natural Alternatives International Inc. (Nasdaq: NAII) gave back 13.97 percent in price Monday to $5.85, on volume of 231,737 shares, swarming its daily average of 15,446. NAII, based in San Marcos, Calif., is a leading formulator, manufacturer and marketer of customized nutritional supplements.

Tags: , , , , , , ,
Posted in Health Care Stocks, Technology Stocks | No Comments »

ARNA stronger, HBAN volume leader, RXII tumbles

Monday, December 20th, 2010

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) pushed upward 23.64 percent in price Monday to $2.04. Volume of 14,985,720 shares nearly doubled its full-day average. The San Diego-based ARNA is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors.

Huntington Bancshares Inc. (Nasdaq: HBAN) traded in 27,626,739 shares, bested its daily average by a half. Share prices for HBAN moved moderately ahead 4.98 percent to $6.54. Columbus-based HBAN is a $53-billion regional bank holding company

RXi Pharmaceuticals Corp. (Nasdaq: RXII) stumbled in price 11.43 percent Monday to $2.79, on volume of 705,157 shares, nearly quadrupled its full-day average. RXII is a recognized leader in RNAi-based therapeutic discovery and development

Tags: , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | No Comments »

« Older Entries
Newer Entries »